logo
Charity founder tackling loneliness in people with cancer through letter writing

Charity founder tackling loneliness in people with cancer through letter writing

Yahoo29-01-2025

A charity founder hopes to 'reduce loneliness and isolation' among people living with cancer through a 24-hour letter writing marathon for World Cancer Day.
Alison Hitchcock, 56, is co-founder of From Me To You Letters, a charity supporting people living with cancer by sending them letters, and has created a 24-hour event to mark World Cancer Day which falls on February 4.
The 24-hour Letter Writing Marathon hopes to bring together writers from across the globe via an online video link to spend an hour of their day writing and sharing letters in a bid to combat isolation among people living with cancer.
'This is an opportunity for us all to come together and just be part of something where we are thinking about people who have cancer, but we're actively doing something to support them as well,' Ms Hitchcock, from Blandford in Dorset, told the PA news agency.
'I think the marathon is a real, tangible proof of the number of people who we've been able to connect with and who have wanted to connect with what we do.'
She hopes the free event, which will take place from 9am on Saturday February 8 until 9am on Sunday February 9, will help people realise they are 'making a difference' to people living with cancer.
'What we hope is that often when people want to write to somebody who's living with cancer they just don't know how to go about it, so this will enable them, will give them the tools to do that (write a letter),' Ms Hitchcock said.
'If it just means that they then reach out to maybe an auntie or a cousin or a dad with a letter or a card… then that will have just started to reduce some of the loneliness and isolation that a cancer diagnosis can bring.'
Ms Hitchcock said the event is designed to 'show you how to connect and how to support someone who's living with cancer' and will be hosted remotely via a Zoom link to allow people from around the world in different time zones to participate.
The charity began in 2017 after fellow co-founder Brian Greenley was diagnosed with stage three bowel cancer in 2010, and Ms Hitchcock offered to write him letters after he mentioned feeling isolated and lonely.
Over the following two years, Mr Greenley's cancer moved to stage four before he was cancer-free in 2013.
'As a friend, I felt really helpless as to how I could support him and so I just came up with this wacky idea that I would write letters to him,' Ms Hitchcock said.
She said her letters helped Mr Greenley through a difficult few years after he underwent several surgeries for his cancer.
'He said my letters made him smile,' Ms Hitchcock said.
'They let him know that he wasn't alone, and they became a really important part of his cancer experience and something that he came to rely on as part of the support.
'We then set up the charity to say to people, 'Look, you can support your friends and family and loved ones in this really simple way'.'
The charity takes anonymous letters from people from across the globe before they are repackaged and distributed to hospitals, cancer centres and individuals monthly.
She said last year the charity distributed 13,500 letters to people living with cancer.
The charity was recognised by the Princess of Wales at her Christmas carol service, which Ms Hitchcock said she was 'blown away' by.
'We were just so incredibly touched that of all the charities that she could have chosen to identify with on that particular occasion, she chose to identify with us,' she said.
To learn more about the writing marathon and to join the event, you can visit: https://www.tickettailor.com/events/frommetoyou/1494709

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Here's Why Vaxcyte (PCVX) Sold Off in Q1
Here's Why Vaxcyte (PCVX) Sold Off in Q1

Yahoo

time27-05-2025

  • Yahoo

Here's Why Vaxcyte (PCVX) Sold Off in Q1

Carillon Tower Advisers, an investment management company, released its 'Carillon Eagle Small Cap Growth Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. Small-cap stocks experienced a significant drop in Q1, with the Russell 2000 Growth Index (down 11.12%) trailing the Russell 2000 Value Index (down 7.74%). In the Russell 2000 Growth Index, real estate, which increased by 1.76%, outperformed all sectors both absolutely and relatively. The only other sector delivering positive returns was consumer staples, which rose by 0.67%. In addition, please check the fund's top five holdings to know its best picks in 2025. In its first-quarter 2025 investor letter, Carillon Eagle Small Cap Growth Fund highlighted stocks such as Vaxcyte, Inc. (NASDAQ:PCVX). Vaxcyte, Inc. (NASDAQ:PCVX) is a clinical-stage biotechnology vaccine company that focuses on developing novel protein vaccines to prevent or treat bacterial infectious diseases. The one-month return of Vaxcyte, Inc. (NASDAQ:PCVX) was -1.09%, and its shares lost 52.68% of their value over the last 52 weeks. On May 23, 2025, Vaxcyte, Inc. (NASDAQ:PCVX) stock closed at $32.54 per share with a market capitalization of $4.198 billion. Carillon Eagle Small Cap Growth Fund stated the following regarding Vaxcyte, Inc. (NASDAQ:PCVX) in its Q1 2025 investor letter: "Vaxcyte, Inc. (NASDAQ:PCVX) is a leading biotechnology company focused on developing vaccines. The company is developing VAX24/VAX-31 for the prevention of pneumococcal disease in infants and adults. Phase 2 trial results for VAX-24 in infants were announced, demonstrating non-inferiority to another drug on nearly all serotypes tested. While the results were promising enough to proceed to phase 3, they were not as robust as previous VAX-24 trials. Additionally, the resignation of a key U.S. Food and Drug Administration leader, Dr. Peter Marks, shortly before the results were unveiled, raised concerns in the vaccine industry and contributed to a significant selloff in the stock. Despite these challenges, the company remains optimistic about the future of VAX-24 in phase 3 trials." A research scientist in a laboratory holding a vial of a biotechnology drug. Vaxcyte, Inc. (NASDAQ:PCVX) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held Vaxcyte, Inc. (NASDAQ:PCVX) at the end of the first quarter, which was 50 in the previous quarter. While we acknowledge the potential of Vaxcyte, Inc. (NASDAQ:PCVX) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered Vaxcyte, Inc. (NASDAQ:PCVX) and shared the list of stocks that will bounce back according to analysts. The fund stated in its Q4 2024 investor letter that Vaxcyte, Inc. (NASDAQ:PCVX) underperformed due to uncertainty surrounding its key vaccine candidates amid political shifts. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey.

Here's Why Vaxcyte (PCVX) Sold Off in Q1
Here's Why Vaxcyte (PCVX) Sold Off in Q1

Yahoo

time27-05-2025

  • Yahoo

Here's Why Vaxcyte (PCVX) Sold Off in Q1

Carillon Tower Advisers, an investment management company, released its 'Carillon Eagle Small Cap Growth Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. Small-cap stocks experienced a significant drop in Q1, with the Russell 2000 Growth Index (down 11.12%) trailing the Russell 2000 Value Index (down 7.74%). In the Russell 2000 Growth Index, real estate, which increased by 1.76%, outperformed all sectors both absolutely and relatively. The only other sector delivering positive returns was consumer staples, which rose by 0.67%. In addition, please check the fund's top five holdings to know its best picks in 2025. In its first-quarter 2025 investor letter, Carillon Eagle Small Cap Growth Fund highlighted stocks such as Vaxcyte, Inc. (NASDAQ:PCVX). Vaxcyte, Inc. (NASDAQ:PCVX) is a clinical-stage biotechnology vaccine company that focuses on developing novel protein vaccines to prevent or treat bacterial infectious diseases. The one-month return of Vaxcyte, Inc. (NASDAQ:PCVX) was -1.09%, and its shares lost 52.68% of their value over the last 52 weeks. On May 23, 2025, Vaxcyte, Inc. (NASDAQ:PCVX) stock closed at $32.54 per share with a market capitalization of $4.198 billion. Carillon Eagle Small Cap Growth Fund stated the following regarding Vaxcyte, Inc. (NASDAQ:PCVX) in its Q1 2025 investor letter: "Vaxcyte, Inc. (NASDAQ:PCVX) is a leading biotechnology company focused on developing vaccines. The company is developing VAX24/VAX-31 for the prevention of pneumococcal disease in infants and adults. Phase 2 trial results for VAX-24 in infants were announced, demonstrating non-inferiority to another drug on nearly all serotypes tested. While the results were promising enough to proceed to phase 3, they were not as robust as previous VAX-24 trials. Additionally, the resignation of a key U.S. Food and Drug Administration leader, Dr. Peter Marks, shortly before the results were unveiled, raised concerns in the vaccine industry and contributed to a significant selloff in the stock. Despite these challenges, the company remains optimistic about the future of VAX-24 in phase 3 trials." A research scientist in a laboratory holding a vial of a biotechnology drug. Vaxcyte, Inc. (NASDAQ:PCVX) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held Vaxcyte, Inc. (NASDAQ:PCVX) at the end of the first quarter, which was 50 in the previous quarter. While we acknowledge the potential of Vaxcyte, Inc. (NASDAQ:PCVX) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered Vaxcyte, Inc. (NASDAQ:PCVX) and shared the list of stocks that will bounce back according to analysts. The fund stated in its Q4 2024 investor letter that Vaxcyte, Inc. (NASDAQ:PCVX) underperformed due to uncertainty surrounding its key vaccine candidates amid political shifts. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Say Goodbye to Red Dye No. 3 and Hello to FDA-Approved Natural Food Dyes
Say Goodbye to Red Dye No. 3 and Hello to FDA-Approved Natural Food Dyes

CNET

time13-05-2025

  • CNET

Say Goodbye to Red Dye No. 3 and Hello to FDA-Approved Natural Food Dyes

The US Food and Drug Administration officially banned Red dye No. 3, a popular food coloring tied to thyroid cancer, in January of this year. Although the decision marks the beginning of the end for the additive, manufacturers still have time to phase it out of their products. On May 9, the FDA announced the approval of three natural food colors derived from natural sources: red algae, butterfly pea flower and calcium phosphate. Here's everything to know about the synthetic red dye and the newly approved natural dyes. What is Red No. 3? Red No. 3 -- also known as FD&C Red No. 3, erythrosine or Red 3 -- is a synthetic dye that is made from petroleum and adds a "bright, cherry-red color" to the products it is added to. In 1990, the FDA banned Red No. 3 in cosmetics, but no law barred the synthetic dye from being added to numerous types of foods and drinks in the decades that followed. The FDA cited the Delaney Clause as its reasoning behind the ban, which "prohibits FDA authorization of a food additive or color additive if it has been found to induce cancer in humans or animals." Although studies did show a link to cancer in laboratory rats, a link between the dye and cancer in humans has not been found. "While there are studies noting carcinogenicity in male rats, the FDA noted in their announcement that the hormonal mechanism through which the dye caused cancer in rats is specific to the animal and does not occur in humans," Bryan Hitchcock, chief science and technology officer of the Institute of Food Technologists, told CNET. Hitchcock added that the studies used large amounts of the dye, which is more than what the average human would consume when eating the foods that contain it. "Studies testing Red No. 3 for human safety have done so at amounts well above the average amount of consumption, as noted by various global regulatory bodies," he says. "The studies referenced by the FDA note that the rats were given roughly 200 times the likely maximum daily consumption of .25 mg/kg of body weight per day." Foods that contain Red No. 3 Here are 9 common types of foods that contain Red No. 3: Candy Cupcakes Cookies Frozen desserts Frostings Icings Certain Maraschino cherries Certain processed meats and meat substitutes Red No. 3 has previously been banned in other countries, including items that currently have Red No. 3 on their ingredient list are: Numerous types of Brach's candy, including Classic Jelly Beans, Spiced Jelly Beans and Conversation Hearts MorningStar Farms Plant-Based Bacon Strips Good Humor Strawberry Shortcake Frozen Dessert Bars Pez candy According to a list compiled by some drugs that have Red No. 3 include: Acetaminophen Doxycycline Monohydrate Gabapentin Vyvanse The Environmental Working Group has compiled a searchable database of food products that use the now-banned dye. As of April 29, 2025, the site had collected 3,225 products that list Red No. 3 as an ingredient. When do companies need to remove Red No. 3 from products? Despite the ban, don't expect to see the Red No. 3 ingredient disappear from ingredient lists too quickly. According to the FDA, companies have a couple of years to remove it from their products. "Manufacturers who use FD&C Red No. 3 in food and ingested drugs will have until January 15, 2027, or January 18, 2028, respectively, to reformulate their products," the FDA statement reads. What will replace Red No. 3? Red Dye No. 3 will soon be replaced by food coloring made from beets and other natural ingredients. istetiana/Getty Images Givaudan Sense Colour, a manufacturing company that creates natural food and drink colorings, highlighted three possible alternatives to Red No. 3 -- carmine, which is made from bugs; betacyanins, found in beetroots; and anthocyanins, derived from fruits and vegetables. California Assembly member Jesse Gabriel told NBC News that although synthetic dyes can be cheaper than other alternatives, he does not believe that the Red No. 3 ban will cause prices of the affected products to change. "We don't expect the price of any food to increase," he told the outlet. New natural food dyes approved by the FDA In May of this year, the FDA approved three natural food dye colors. The first is Galdieria extract blue, which is derived from a species of red algae. According to a press release, this food color has been approved to be added to "nonalcoholic beverages and beverage bases, fruit drinks, fruit smoothies, fruit juices, vegetable juices, dairy-based smoothies, milk shakes and flavored milks, yogurt drinks, milk-based meal replacement and nutritional beverages, breakfast cereal coatings, hard candy, soft candy and chewing gum." Butterfly pea flower has also been approved to create blues, purples and greens. This popular natural food dye is already used in sports drinks, teas, alcoholic beverages and more. However, the new approval now allows the dye to be used in "ready-to-eat cereals, crackers, snack mixes, hard pretzels, plain potato chips (restructured or baked), plain corn chips, tortilla chips and multigrain chips." Lastly, the mineral, chlorine phosphate, and its white color has been approved for "ready-to-eat chicken products, white candy melts, doughnut sugar and sugar for coated candies," per the release. Will Red 40 be banned? The FDA has not yet banned red dye No. 40, but discussions are ongoing. According to a press release from April 22, 2025, the FDA plans to eventually phase out all petroleum-based synthetic dyes, which include Red No. 40. Are other syntethic food colorings safe? After the Red No. 3 ban, there are now eight approved color additives (but this may change under the current administration). They are FD&C Blue No. 1, FD&C Blue No. 2, FD&C Green No. 3, Orange B, Citrus Red No. 2, FD&C Red No. 40, FD&C Yellow No. 5 and FD&C Yellow No. 6. Hitchcock says that so far, studies show that there is not a notable risk to consuming these dyes. "While science tells us that there is little to no risk in consuming other synthetic dyes, it is important that we continue to monitor and evaluate food ingredient safety," he says. "It is paramount that we continue to invest in more scientific research around the health of our foods to ensure safety and provide peace of mind for consumers." According to the FDA, the above dyes do not pose the same possible risks as Red No. 3, which is why they are still available for use in the US. But, some studies show possible links between certain dyes and potential health conditions. For example, some studies have linked Red 40 to hyperactivity, according to the Cleveland Clinic, but further studies are still needed to determine a direct link between the dye and the condition. When asked about the safety of other food dyes, Hitchcock highlighted the need for transparency from the FDA, which he says the agency has been addressing. "We believe there needs to be a clear framework for post-market review for food additive safety," Hitchcock says. "The FDA is actively working to address this issue as seen in their Development of an Enhanced Systematic Process for the FDA's Post-Market Assessment of Chemicals in Food. IFT believes that the FDA needs to bring forward a post-market assessment of chemical food safety that is transparent, scientifically grounded, constituent informed and timely." If a drink looks too red to be natural, it probably is. Images Does food coloring have a taste? Most foods contain food coloring in such small amounts that you won't notice a specific taste. However, some food coloring brands, types or certain colors (like red) may taste slightly bitter if a lot is used. The bottom line on Red No. 3 Red No. 3 has been fully banned in the US, but will continue to be used in food for the next two years as manufacturers work to change their recipes. However, some manufacturers are making changes much more quickly than that. In an email to CBS News, Keurig Dr Pepper said that a "new formula" for Yoo-hoo Strawberry Flavored Drink, which is currently made with Red No. 3 to help achieve its color, "will be on shelves before the end of the year."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store